Related Experiment Video
Updated: Jul 18, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral valve replacement in patients of rheumatic heart disease associated with immune thrombocytopenia
Vikas Deep Goyal1, Akhilesh Pahade2, Gaurav Misra2
1Department of Surgery, SRMS, IMS, Bareilly, UP 243202 India.
Abstract:
Immune thrombocytopenia in association with rheumatic heart disease is not commonly seen. Surgical management of rheumatic heart disease becomes more challenging in the presence of immune thrombocytopenia. The risk of complications increases manifold and judicious medical management before, during, and after surgery is imperative. We discuss two such cases, the complications we faced and the problems we anticipated before, and their prevention. Both patients were managed without using immunoglobulins or doing splenectomy. The literature on valve replacement in patients of immune thrombocytopenia and the implications of immune thrombocytopenia in the management of patients with rheumatic heart disease is also reviewed.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

